MEDICALLY MONITORED AT-HOME KETAMINE THERAPY: RENEWED HOPE FOR TREATMENT-RESISTANT DEPRESSION
Treatment-Resistant Depression (TRD) is diagnosed when an individual’s mood and daily functioning disturbances do not show improvement after two courses of different antidepressants, each taken for at least six weeks, or they may improve but sporadically return. These are the hallmarks of Treatment-Resistant Depression (TRD). Neuroscientists have found that depression can cause shrinkage of the […]